To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2086
Peptide Name Sequence 23 from Patent US9221874B2
Sequence RRKKWLLALLAP
Sequence Length 12
Source Synthetic peptide
Target Organism influenza virus
Patent Type Granted Patent
Publication Date 2015-12-29
Patent No US9221874B2
Family Info WO2009152519A2, US20120165249A1, US8129499B2, CA2727898A1, JP2011524373A, EP2310030A4
Patent Title Antiviral peptides against influenza virus
Comment
Abstract The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.